1. Oettgen HF, Old LJ. The history of cancer immunotherapy. In: DeVita VT Jr, Hellman S, Rosenberg SA, editors. Biologic therapy of cancer. Philadelphia (PA): JB Lippincott Co.; 1991. p. 87-119.

2. Day EA. The immunochemistry of cancer. Springfield (IL): Charles C. Thomas Publisher; 1965.

3. Abelev GI, Perova SD, Khramkova NI, Postnikova ZA, Irlin IS. Production of embryonal alpha-globulin by transplantable mouse hepatomas. Transplantation 1963; 1: 174-180.

4. Gold P, Freedman SO. Specific carcinoembryonic antigens of the human digestive system. J Exp Med 1965; 122: 467-481. (PMID: 4953873) [PubMed]

5. Boyse EA, Old LJ. Some aspects of normal and abnormal cell surface genetics. Annu Rev Genet 1969; 3: 269-290.

6. Old LJ, Stockert E. Immunogenetics of cell surface antigens of mouse leukemia. Annu Rev Genet 1977; 11: 127-160. (PMID: 202188) [PubMed]

7. Köhler C, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975; 256: 495-497. (PMID: 1172191) [PubMed]

8. Rettig WJ, Old LJ. Immunogenetics of human cell surface differentiation. Annu Rev Immunol 1989; 7: 481-511. (PMID: 2653374) [PubMed]

9. Old LJ. Cancer immunology: the search for specificity--G.H.A. Lowes Memorial Lecture. Cancer Res 1981; 41: 361-375. (PMID: 7004632) [PubMed]

10. Garrett TJ, Takahashi T, Clarkson BD, Old LJ. Detection of antibody to autologous human leukemia cells by immune adherence assay. Proc Natl Acad Sci USA 1977; 74: 4587-4590. (PMID: 270702) [PubMed]

11. Carey TE, Takahashi T, Resnick LA, Oettgen HF, Old LJ. Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc Natl Acad Sci USA 1976; 73: 3278-3282. (PMID: 1067619) [PubMed]

12. Shiku H, Takahashi T, Oettgen HF. Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens. J Exp Med 1976; 144: 873-881. (PMID: 978138) [PubMed]

13. Ueda R, Shiku H, Pfreundschuh M, Takahashi T, Li LT, Whitmore WF, Oettgen HF, Old LJ. Cell surface antigens of human renal cancer defined by autologous typing. J Exp Med 1979; 150: 564-579. (PMID: 479762) [PubMed]

14. Pfreundschuh M, Shiku H, Takahashi T, Ueda R, Ransohoff J, Oettgen HF, Old LJ. Serological analysis of cell surface antigens of malignant human brain tumors. Proc Natl Acad Sci USA 1978; 75: 5122-5126. (PMID: 283420) [PubMed]

15. Carey TE, Lloyd KO, Takahashi T, Travassos LR, Old LJ. AU cell-surface antigen of human malignant melanoma: solubilization and partial characterization. Proc Natl Acad Sci USA 1979; 76: 2898-2902. (PMID: 313568) [PubMed]

16. Watanabe T, Pukel CS, Takeyama H, Lloyd KO, Shiku H, Li LT, Travassos LR, Oettgen HF, Old LJ. Human melanoma antigen AH is an autoantigenic ganglioside related to GD2. J Exp Med 1982; 156: 1884-1889. (PMID: 7175442) [PubMed]

17. Real FX, Mattes MJ, Houghton AN, Oettgen HF, Lloyd KO, Old LJ. Class 1 (unique) antigens of melanoma: identification of a 90,000 dalton cell surface glycoprotein by autologous antibody. J Exp Med 1984; 160: 1219-1233. (PMID: 6237165) [PubMed]

18. Mattes MJ, Thomson TM, Old LJ, Lloyd KO. A pigmentation-associated differentiation antigen of human melanoma defined by a precipitating antibody in human serum. Int J Cancer 1983; 32: 717-721. (PMID: 6197381) [PubMed]

19. Sahin U, Türeci O, Schmitt H, Cochlovius B, Johannes T, Schmits R, Stenner F, Luo G, Schobert I, Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci USA 1995; 92: 11810-11813. (PMID: 8524854) [PubMed]

20. Sahin U, Türeci 0, Pfreundschuh M. Serological identification of human tumor antigens. Curr Opin Immunol 1997; 9: 709-716. (PMID: 9368781) [PubMed]

21. Türeci 0, Schmitt H, Fadle N, Pfreundschuh M, Sahin U. Molecular definition of a novel human galactin which is immunogenic in patients with Hodgkin's disease. J Biol Chem 1997; 272: 6416-6422. (PMID: 9045665) [PubMed]

22. Güre AO, Türeci O, Sahin U, Tsang S, Scanlan MJ, Jäger E, Knuth A, Pfreundschuh M, Old LJ, Chen YT. SSX, a multigene family with several members transcribed in normal testis and human cancer. Int J Cancer 1997; 72: 965-971. (PMID: 9378559) [PubMed]

23. Türeci 0, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M. Identification of a meiosis-specific protein as a new member of the class of cancer/testis antigens. Proc Natl Acad Sci USA 1998; 95: 5211-5216. (PMID: 9560255) [PubMed]

24. Türeci O, Sahin U, Koslowski M, Buss B, Bell C, Ballweber P, Zwick C, Eberle T, Zuber M, Villena-Heinsen C, Seitz G, Pfreundschuh M. A novel tumour associated leucine zipper protein targeting to sites of gene transcription and splicing. Oncogene 2002; 21: 3879-3888. (PMID: 12032826) [PubMed]

25. Chen YT, Güre AO, Tsang S, Stockert E, Jäger E, Knuth A, Old LJ. Identification of multiple cancer/ testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc Natl Acad Sci USA 1998; 95: 6919-6923. (PMID: 9618514) [PubMed]

26. O'Neill MJ, Sinclair AH. Isolation of rare transcripts by representational difference analysis. Nucleic Acids Res 1997; 25: 2681-2682. (PMID: 9185582) [PubMed]

27. Güre AO, Stockert E, Arden KC, Boyer AD, Viars CS, Scanlan MJ, Old LJ, Chen YT. CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis. Int J Cancer 2000; 85: 726-732. (PMID: 10699956) [PubMed]

28. Chen YT, Scanlan MJ, Sahin U, Türeci O, Güre AO, Tsang S, Williamson B, Stockert E, Pfreundschuh M, Old LJ. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc Natl Acad Sci USA 1997; 94: 1914-1918. (PMID: 9050879) [PubMed]

29. Scanlan MJ, Chen YT, Williamson B, Güre AO, Stockert E, Gordan JD, Türeci O, Sahin U, Pfreundschuh M, Old LJ. Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 1998; 76: 652-658. (PMID: 9610721) [PubMed]

30. Brass N, Heckel D, Sahin U, Pfreundschuh M, Sybrecht GW, Meese E. Translation initiation factor eIF-4gamma is encoded by an amplified gene and induces an immune response in squamous cell lung carcinoma. Hum Mol Genet 1997; 6: 33-39. (PMID: 9002667) [PubMed]

31. Brass N, Racz A, Bauer C, Heckel D, Sybrecht G, Meese E. Role of amplified genes in the production of autoantibodies. Blood 1999; 93: 2158-2166. (PMID: 10090922) [PubMed]

32. Güre AO, Altorki NK, Stockert E, Scanlan MJ, Old LJ, Chen YT. Human lung cancer antigens recognized by autologous antibodies: definition of a novel cDNA derived from the tumor suppressor gene locus on chromosome 3p21.3. Cancer Res 1998; 58: 1034-1041. (PMID: 9500467) [PubMed]

33. Scanlan MJ, Gordan JD, Williamson B, Stockert E, Bander NH, Jongeneel V, Güre AO, Jäger D, Jäger E, Knuth A, Chen YT, Old LJ. Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 1999; 83: 456-464. (PMID: 10508479) [PubMed]

34. Obata Y, Takahashi T, Sakamoto J, Tamaki H, Tominaga S, Hamajima N, Chen YT, Old LJ. SEREX analysis of gastric cancer antigens. Cancer Chemother Pharmacol 2000; 46 Suppl: S37-S42. (PMID: 10950146) [PubMed]

35. Jäger D, Stockert E, Scanlan MJ, Güre AO, Jäger E, Knuth A, Old LJ, Chen YT. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homolog gene. Cancer Res 1999; 59: 6197-6204. (PMID: 10626813) [PubMed]

36. Scanlan MJ, Gout I, Gordon CM, Williamson B, Stockert E, Güre AO, Jäger D, Chen YT, Mackay A, O'Hare MJ, Old LJ. Humoral immunity to human breast cancer: antigen definition and quantitative analysis of mRNA expression. Cancer Immun 2001; 1: 4. URL: http://www.cancerimmunity.org/v1p4/010202.htm (PMID: 12747765) [Abstract]

37. Obata Y, T Akahashi T, Tamaki H, Tominaga S, Murai H, Iwase T, Iwata H, Mizutani M, Chen YT, Old LJ, Miura S. Identification of Cancer Antigens in Breast Cancer by the SEREX Expression Cloning Method. Breast Cancer 1999; 6: 305-311. (PMID: 11091735) [PubMed]

38. Chen YT, Güre AO, Scanlan MJ, Jäger E, Knuth A, Old LJ. Unpublished data, 1999.

39. Obata Y. Personal communication, 2001.

40. Ling M, Wen YJ, Lim SH. Prevalence of antibodies against proteins derived from leukemia cells in patients with chronic myeloid leukemia. Blood 1998; 92: 4764-4770. (PMID: 9845543) [PubMed]

41. Lethé B, Lucas S, Michaux L, De Smet C, Godelaine D, Serrano A, De Plaen E, Boon T. LAGE-1, a new gene with tumor specificity. Int J Cancer 1998; 76: 903-908. (PMID: 9626360) [PubMed]

42. Müller-Pillasch F, Lacher U, Wallrapp C, Micha A, Zimmerhackl F, Hameister H, Varga G, Friess H, Buchler M, Beger HG, Vila MR, Adler G, Gress TM. Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein. Oncogene 1997; 14: 2729-2733. (PMID: 9178771) [PubMed]

43. Zhang JY, Chan EK, Peng XX, Tan EM. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. J Exp Med 1999; 189: 1101-1110. (PMID: 10190901) [PubMed]

44. Huflejt ME, Jordan ET, Gitt MA, Barondes SH, Leffler H. Strikingly different localization of galectin-3 and galectin-4 in human colon adenocarcinoma T84 cells: galectin-4 is localized at sites of cell adhesion. J Biol Chem 1997; 272: 14294-14303. (PMID: 9162064) [PubMed]

45. Scanlan MJ, Williamson B, Jungbluth A, Stockert E, Arden KC, Viars CS, Güre AO, Gordan JD, Chen YT, Old LJ. Isoforms of the human PDZ-73 protein exhibit differential tissue expression. Biochem Biophys Acta 1999; 1445: 39-52. (PMID: 10209257) [PubMed]

46. Ponting CP, Phillips C, Davies KE, Blake DJ. PDZ domains: targeting signaling molecules to sub-membranous sites. Bioessays 1997; 19: 469-479. (PMID: 9204764) [PubMed]

47. Van den Eynde BJ, van der Bruggen P. T cell defined tumor antigens. Curr Opin Immunol 1997; 9: 684-693. (PMID: 9368778) [PubMed]

48. Geiger B, Ayalon O. Cadherins. Annu Rev Cell Biol 1992; 8: 307-332. (PMID: 1476802) [PubMed]

49. Takeichi M. Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 1993; 5: 806-811. (PMID: 8240824) [PubMed]

50. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature 1998; 392: 402-405. (PMID: 9537325) [PubMed]

51. Staal SP. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. Proc Natl Acad Sci USA 1987; 84: 5034-5037. (PMID: 3037531) [PubMed]

52. Türeci O, Sahin U, Vollmar E, Siemer S, Gottert E, Seitz G, Parkkila AK, Shah GN, Grubb JH, Pfreundschuh M, Sly WS. Human carbonic anhydrase XII: cDNA cloning, expression, and chromosomal localization of a carbonic anhydrase gene that is overexpressed in some renal cell cancers. Proc Natl Acad Sci USA 1998; 95: 7608-7613. (PMID: 9636197) [PubMed]

53. Kok K, Naylor SL, Buys CH. Deletions of the short arm of chromosome 3 in solid tumors and the search for tumor suppressor genes. Adv Cancer Res 1997; 71: 27-92. (PMID: 9111863) [PubMed]

54. van den Berg A, Hulsbeek MF, de Jong D, Kok K, Veldhuis PM, Roche J, Buys CH. Major role for a 3p21 region and lack of involvement of the t(3;8) breakpoint region in the development of renal cell carcinoma suggested by loss of heterozygosity analysis. Genes Chrom Cancer 1996; 15: 64-72. (PMID: 8824727) [PubMed]

55. Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Muller O, Back W, Zimmer M. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 1998; 18: 38-43. (PMID: 9425897) [PubMed]

56. Dong SM, Kim KM, Kim SY, Shin MS, Na EY, Lee SH, Park WS, Yoo NJ, Jang JJ, Yoon CY, Kim JW, Kim SY, Yang YM, Kim SH, Kim CS, Lee JY. Frequent somatic mutations in serine/threonine kinase 11/Peutz-Jeghers syndrome gene in left-sided colon cancer. Cancer Res 1998; 58: 3787-3790. (PMID: 9731485) [PubMed]

57. Bignell GR, Barfoot R, Seal S, Collins N, Warren W, Stratton MR. Low frequency of somatic mutations in the LKB1/Peutz-Jeghers syndrome gene in sporadic breast cancer. Cancer Res 1998; 58: 1384-1386. (PMID: 9537235) [PubMed]

58. Park WS, Moon YW, Yang YM, Kim YS, Kim YD, Fuller BG, Vortmeyer AO, Fogt F, Lubensky IA, Zhuang Z. Mutations of the STK11 gene in sporadic gastric carcinoma. Int J Oncol 1998; 13: 601-604. (PMID: 9683800) [PubMed]

59. Hariharan IK, Adams JM. cDNA sequence for human bcr, the gene that translocates to the abl oncogene in chronic myeloid leukaemia. EMBO J 1987; 6: 115-119. (PMID: 3107980) [PubMed]

60. Iida A, Kurose K, Isobe R, Akiyama F, Sakamoto G, Yoshimoto M, Kasumi F, Nakamura Y, Emi M. Mapping of a new target region of allelic loss to a 2-cM interval at 22q13.1 in primary breast cancer. Genes Chromosomes Cancer 1998; 21: 108-112. (PMID: 9491321) [PubMed]

61. Chowdhury K, Goulding M, Walther C, Imai K, Fickenscher H. The ubiquitous transactivator Zfp-38 is unregulated during spermatogenesis with differential transcription. Mech Dev 1992; 39: 129-142. (PMID: 1284028) [PubMed]

62. Brass N, Ukena I, Remberger K, Mack U, Sybrecht GW, Meese EU. DNA amplification on chromosome 3q26.1-q26.3 in squamous cell carcinoma of the lung detected by reverse chromosome painting. Eur J Cancer 1996; 32A: 1205-1208. (PMID: 8758254) [PubMed]

63. Ojila T, Imaizumi M, Abe T, Kato K. Immunochemical and immunohistochemical studies on three aldolase isozymes in human lung cancer. Cancer 1991; 67: 2153-2158. (PMID: 2004336) [PubMed]

64. Asaka M, Kimura T, Meguro T, Kato M, Kudo M, Miyazaki T, Alpert E. Alteration of aldolase isozymes in serum and tissues of patients with cancer and other diseases. J Clin Lab Anal 1994; 8: 144-148. (PMID: 8046542) [PubMed]

65. Garkavtsev I, Kazarov A, Gudkov A, Riabowol K. Suppression of the novel growth inhibitor p33ING1 promotes neoplastic transformation. Nat Genet 1996; 14: 415-420. (PMID: 8944021) [PubMed]

66. Walter L, Marynen P, Szpirer J, Levan G, Gunther E. Identification of a novel conserved human gene, TEGT. Genomics 1995; 28: 301-304. (PMID: 8530040) [PubMed]

67. Boon T, van der Bruggen P. Human tumor antigens recognized by T lymphocytes. J Exp Med 1996; 183: 725-729. (PMID: 8642276) [PubMed]

68. Lucas S, De Smet C, Arden KC, Viars CS, Lethe B, Lurquin C, Boon T. Identification of a new MAGE gene with tumor-specific expression by representational difference analysis. Cancer Res 1998; 58: 743-752. (PMID: 9485030) [PubMed]

69. Chen YT, Scanlan MJ, Simpson A, et al. Unpublished data, 2004.

70. Zorn E, Hercend T. A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion. Eur J Immunol 1999; 29: 602-607. (PMID: 10064076) [PubMed]

71. Crew AJ, Clark J, Fisher C, Gill S, Grimer R, Chand A, Shipley J, Gusterson BA, Cooper CS. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J 1995; 14: 2333-2340. (PMID: 7539744) [PubMed]

72. De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T. The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci USA 1996; 93: 7149-7153. (PMID: 8692960) [PubMed]

73. Meuwissen RL, Meerts I, Hoovers JM, Leschot NJ, Heyting C. Human synaptonemal protein 1 (SCP1): isolation and characterization of the cDNA and chromosomal localization of the gene. Genomics 1997; 39: 377-384. (PMID: 9119375) [PubMed]

74. Peptide database of T-cell defined tumor antigens. URL: http://www.cancerimmunity.org/peptidedatabase/Tcellepitopes.htm [Database]

75. Reich NC, Oren M, Levine AJ. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53. Mol Cell Biol 1983; 3: 2143-2150. (PMID: 6318085) [PubMed]

76. Herrmann M, Hagenhofer M, Kalden JR. Retrovirus and systemic lupus erythematosus. Immunol Rev 1996; 152: 145-156. (PMID: 8930671) [PubMed]

77. Walchner M, Leib-Mosch C, Messer G, Germaier H, Plewig G, Kind P. Endogenous retroviral sequences in the pathogenesis of systemic autoimmune disease. Arch Dermatol 1997; 133: 767-771. (PMID: 9197833) [PubMed]

78. Herbst H, Sauter M, Mueller-Lantzsch N. Expression of human endogenous retrovirus K elements in germ cell and trophoblastic tumors. Am J Pathol 1996; 149: 1727-1735. (PMID: 8909261) [PubMed]

79. Boller K, Janssen O, Schuldes H, Tonjes RR, Kurth R. Characterization of the antibody response specific for the human endogenous retrovirus HTDV/HERV-K. J Virol 1997; 71: 4581-4588. (PMID: 9151852) [PubMed]

80. Burek CL, Rose NR, editors. Autoantibodies. New York (NY): Raven Press, 1995. p. 207-230.

81. Posner JB. Paraneoplastic syndromes: a brief review. Ann N Y Acad Sci 1997; 835: 83-90. (PMID: 9616764) [PubMed]

82. Dropcho EJ, Chen YT, Posner JB, Old LJ. Cloning of a brain protein identified by autoantibodies from a patient with paraneoplastic cerebellar degeneration. Proc Natl Acad Sci USA 1987; 84: 4552-4556. (PMID: 3474619) [PubMed]

83. Chen YT, Obata Y, Stockert E, Takahashi T, Old LJ. Tla-region genes and their products. Immunol Res 1987; 6: 30-45. (PMID: 3305736) [PubMed]

84. Schlichtholz B, Legros Y, Gillet D, Gaillard C, Marty M, Lane D, Calvo F, Soussi T. The immune response to p53 in breast cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Res 1992; 52: 6380-6384. (PMID: 1423285) [PubMed]

85. Stockert E, Jäger E, Chen YT, Scanlan MJ, Gout I, Karbach J, Arand M, Knuth A, Old LJ. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J Exp Med 1998; 187: 1349-1354. (PMID: 9547346) [PubMed]

86. Jäger E, Chen YT, Drijfhout JW, Karbach J, Ringhoffer M, Jäger D, Arand M, Wada H, Noguchi Y, Stockert E, Old LJ, Knuth A. Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes. J Exp Med 1998; 187: 265-270. (PMID: 9432985) [PubMed]

87. Jäger E, Jäger D, Karbach J, Chen YT, Ritter G, Nagata Y, Gnjatic S, Stockert E, Arand M, Old LJ, Knuth A. Identification of NY-ESO-1 epitopes presented by human histocompatibility antigen (HLA)-DRB4*0101-0103 and recognized by CD4(+) T lymphocytes of patients with NY-ESO-1-expressing melanoma. J Exp Med 2000; 191: 625-630. (PMID: 10684854) [PubMed]

88. Kawakami Y, Rosenberg SA. Human tumor antigens recognized by T-cells. Immunol Res 1997; 16: 313-339. (PMID: 9439758) [PubMed]

89. Jager D, Stockert E, Jager E, Gure AO, Scanlan MJ, Knuth A, Old LJ, Chen YT. Serological cloning of a melanocyte rab guanosine 5'-triphosphate-binding protein and a chromosome condensation protein from a melanoma complementary DNA library. Cancer Res 2000; 60: 3584-91. (PMID: 10910072) [PubMed]

90. Mollick JA, Hodi FS, Soiffer RJ, Nadler LM, Dranoff G. MUC1-like tandem repeat proteins are broadly immunogenic in cancer patients. Cancer Immun 2003; 3: 3. URL: http://www.cancerimmunity.org/v3p3/030203.htm (PMID: 12747745) [Abstract]

91. Ehlken H, Schadendorf D, Eichmuller S. Humoral immune response against melanoma antigens induced by vaccination with cytokine gene-modified autologous tumor cells. Int J Cancer 2004; 108: 307-13. (PMID: 14639620) [PubMed]

92. Line A, Slucka Z, Stengrevics A, Silina K, Li G, Rees RC. Characterisation of tumour-associated antigens in colon cancer. Cancer Immunol Immunother 2002; 51: 574-82. (PMID: 12384809) [PubMed]

93. Ishikawa T, Fujita T, Suzuki Y, Okabe S, Yuasa Y, Iwai T, Kawakami Y. Tumor-specific immunological recognition of frameshift-mutated peptides in colon cancer with microsatellite instability. Cancer Res 2003; 63: 5564-72. (PMID: 14500396) [PubMed]

94. Koroleva EP, Lagarkova MA, Mesheryakov AA, Scanlan MJ, Old LJ, Nedospasov SA, Kuprash DV. Serological identification of antigens associated with renal cell carcinoma. Russ J Immunol 2002; 7: 229-38. (PMID: 12674932) [PubMed]

95. Diesinger I, Bauer C, Brass N, Schaefers HJ, Comtesse N, Sybrecht G, Meese E. Toward a more complete recognition of immunoreactive antigens in squamous cell lung carcinoma. Int J Cancer 2002; 102: 372-8. (PMID: 12402307) [PubMed]

96. Park S, Lim Y, Lee D, Cho B, Bang YJ, Sung S, Kim HY, Kim DK, Lee YS, Song Y, Jeoung DI. Identification and characterization of a novel cancer/testis antigen gene CAGE-1. Biochim Biophys Acta 2003; 1625: 173-82. (PMID: 12531476) [PubMed]

97. Ali Eldib AM, Ono T, Shimono M, Kaneko M, Nakagawa K, Tanaka R, Noguchi Y, Nakayama E. Immunoscreening of a cDNA library from a lung cancer cell line using autologous patient serum: Identification of XAGE-1b as a dominant antigen and its immunogenicity in lung adenocarcinoma. Int J Cancer 2004; 108: 558-63. (PMID: 14696120) [PubMed]

98. Gure AO, Stockert E, Scanlan MJ, Keresztes RS, Jager D, Altorki NK, Old LJ, Chen YT. Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer. Proc Natl Acad Sci USA 2000; 97: 4198-203. (PMID: 10760287) [PubMed]

99. Jager D, Stockert E, Gure AO, Scanlan MJ, Karbach J, Jager E, Knuth A, Old LJ, Chen YT. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res 2001; 61: 2055-61. (PMID: 11280766) [PubMed]

100. Jager D, Unkelbach M, Frei C, Bert F, Scanlan MJ, Jager E, Old LJ, Chen YT, Knuth A. Identification of tumor-restricted antigens NY-BR-1, SCP-1, and a new cancer/testis-like antigen NW-BR-3 by serological screening of a testicular library with breast cancer serum. Cancer Immun 2002; 2: 5. URL: http://www.cancerimmunity.org/v2p5/020605.htm (PMID: 12747750) [Abstract]

101. Forti S, Scanlan MJ, Invernizzi A, Castiglioni F, Pupa S, Agresti R, Fontanelli R, Morelli D, Old LJ, Pupa SM, Menard S. Identification of breast cancer-restricted antigens by antibody screening of SKBR3 cDNA library using a preselected patient's serum. Breast Cancer Res Treat 2002; 73: 245-56. (PMID: 12160330) [PubMed]

102. Minenkova O, Pucci A, Pavoni E, De Tomassi A, Fortugno P, Gargano N, Cianfriglia M, Barca S, De Placido S, Martignetti A, Felici F, Cortese R, Monaci P. Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients. Int J Cancer 2003; 106: 534-44. (PMID: 12845649) [PubMed]

103. Zhou Y, Toth M, Hamman MS, Monahan SJ, Lodge PA, Boynton AL, Salgaller ML. Serological cloning of PARIS-1: a new TBC domain-containing, immunogenic tumor antigen from a prostate cancer cell line. Biochem Biophys Res Commun 2002; 290: 830-8. (PMID: 11785977) [PubMed]

104. Fossa A, Alsoe L, Crameri R, Funderud S, Gaudernack G, Smeland EB. Serological cloning of cancer/testis antigens expressed in prostate cancer using cDNA phage surface display. Cancer Immunol Immunother 2004; Epub ahead of print. (PMID: 14747957) [PubMed]

105. Stenner-Liewen F, Luo G, Sahin U, Tureci O, Koslovski M, Kautz I, Liewen H, Pfreundschuh M. Definition of tumor-associated antigens in hepatocellular carcinoma. Cancer Epidemiol Biomarkers Prev 2000; 9: 285-90. (PMID: 10750667) [PubMed]

106. Wang Y, Han KJ, Pang XW, Vaughan HA, Qu W, Dong XY, Peng JR, Zhao HT, Rui JA, Leng XS, Cebon J, Burgess AW, Chen WF. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J Immunol 2002; 169: 1102-9. (PMID: 12097419) [PubMed]

107. Uemura M, Nouso K, Kobayashi Y, Tanaka H, Nakamura S, Higashi T, Ono T, Nakayama E, Hanafusa T, Shiratori Y. Identification of the antigens predominantly reacted with serum from patients with hepatocellular carcinoma. Cancer 2003; 97: 2474-9. (PMID: 12733146) [PubMed]

108. Naora H, Montz FJ, Chai CY, Roden RB. Aberrant expression of homeobox gene HOXA7 is associated with mullerian-like differentiation of epithelial ovarian tumors and the generation of a specific autologous antibody response. Proc Natl Acad Sci USA 2001; 98: 15209-14. (PMID: 11742062) [PubMed]

109. Stone B, Schummer M, Paley PJ, Thompson L, Stewart J, Ford M, Crawford M, Urban N, O'Briant K, Nelson BH. Serologic analysis of ovarian tumor antigens reveals a bias toward antigens encoded on 17q. Int J Cancer 2003; 104: 73-84. (PMID: 12532422) [PubMed]

110. Lee SY, Obata Y, Yoshida M, Stockert E, Williamson B, Jungbluth AA, Chen YT, Old LJ, Scanlan MJ. Immunomic analysis of human sarcoma. Proc Natl Acad Sci USA 2003; 100: 2651-6. (PMID: 12601173) [PubMed]

111. Nabeta Y, Kawaguchi S, Sahara H, Ikeda H, Hirohashi Y, Goroku T, Sato Y, Tsukahara T, Torigoe T, Wada T, Kaya M, Hiraga H, Isu K, Yamawaki S, Ishii S, Yamashita T, Sato N. Recognition by cellular and humoral autologous immunity in a human osteosarcoma cell line. J Orthop Sci 2003; 8: 554-9. (PMID: 12898310) [PubMed]

112. Lastowska M, Nacheva E, McGuckin A, Curtis A, Grace C, Pearson A, Bown N. Comparative genomic hybridization study of primary neuroblastoma tumors. United Kingdom Children's Cancer Study Group. Genes Chromosomes Cancer 1997; 18: 162-9. (PMID: 9071568) [PubMed]

113. Vandesompele J, Van Roy N, Van Gele M, Laureys G, Ambros P, Heimann P, Devalck C, Schuuring E, Brock P, Otten J, Gyselinck J, De Paepe A, Speleman F. Genetic heterogeneity of neuroblastoma studied by comparative genomic hybridization. Genes Chromosomes Cancer 1998; 23: 141-52. (PMID: 9739017) [PubMed]

114. Bown N, Cotterill S, Lastowska M, O'Neill S, Pearson AD, Plantaz D, Meddeb M, Danglot G, Brinkschmidt C, Christiansen H, Laureys G, Speleman F, Nicholson J, Bernheim A, Betts DR, Vandesompele J, Van Roy N. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma. N Engl J Med 1999; 340: 1954-61. (PMID: 10379019) [PubMed]

115. Behrends U, Jandl T, Golbeck A, Lechner B, Muller-Weihrich S, Schmid I, Till H, Berthold F, Voltz R, Mautner JM. Novel products of the HUD, HUC, NNP-1 and alpha-internexin genes identified by autologous antibody screening of a pediatric neuroblastoma library. Int J Cancer 2002; 100: 669-77. (PMID: 12209604) [PubMed]

116. Schmits R, Cochlovius B, Treitz G, Regitz E, Ketter R, Preuss KD, Romeike BF, Pfreundschuh M. Analysis of the antibody repertoire of astrocytoma patients against antigens expressed by gliomas. Int J Cancer 2002; 98: 73-7. (PMID: 11857388) [PubMed]

117. Nakatsura T, Senju S, Yamada K, Jotsuka T, Ogawa M, Nishimura Y. Gene cloning of immunogenic antigens overexpressed in pancreatic cancer. Biochem Biophys Res Commun 2001; 281: 936-44. (PMID: 11237751) [PubMed]

118. Robinson C, Callow M, Stevenson S, Scott B, Robinson BW, Lake RA. Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities. Am J Respir Cell Mol Biol 2000; 22: 550-6. (PMID: 10783126) [PubMed]

119. Monji M, Senju S, Nakatsura T, Yamada K, Sawatsubashi M, Inokuchi A, Nishimura Y. Head and neck cancer antigens recognized by the humoral immune system. Biochem Biophys Res Commun 2002; 294: 734-41. (PMID: 12056832) [PubMed]

120. Behrends U, Schneider I, Rossler S, Frauenknecht H, Golbeck A, Lechner B, Eigenstetter G, Zobywalski C, Muller-Weihrich S, Graubner U, Schmid I, Sackerer D, Spath M, Goetz C, Prantl F, Asmuss HP, Bise K, Mautner J. Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries. Int J Cancer 2003; 106: 244-51. (PMID: 12800201) [PubMed]

121. Nakatsura T, Senju S, Ito M, Nishimura Y, Itoh K. Cellular and humoral immune responses to a human pancreatic cancer antigen, coactosin-like protein, originally defined by the SEREX method. Eur J Immunol 2002; 32: 826-36. (PMID: 11870627) [PubMed]

122. Huang S, Preuss KD, Xie X, Regitz E, Pfreundschuh M. Analysis of the antibody repertoire of lymphoma patients. Cancer Immunol Immunother 2002; 51: 655-62. (PMID: 12439611) [PubMed]

123. Xie X, Schmits R, Renner C, Preuss D, Kubuschok B, Pfreundschuh M. Systematic search and molecular characterization of the antigenic targets of myeloma immunoglobulins: a monoclonal IgA from a female patient targeting sperm-specific cylicin II. Cancer Immun 2001; 1: 11. URL: http://www.cancerimmunity.org/v1p11/011211.htm (PMID: 12747772) [Abstract]

124. Eichmuller S, Usener D, Dummer R, Stein A, Thiel D, Schadendorf D. Serological detection of cutaneous T-cell lymphoma-associated antigens. Proc Natl Acad Sci USA 2001; 98: 629-34. (PMID: 11149944) [PubMed]

125. Rogers SA, Bowen DJ, Ling M, Thomson P, Wang Z, Lim SH. Identification and characterization of a novel gene encoding a SEREX antigen in chronic myeloid leukaemia. Br J Haematol 2002; 119: 112-4. (PMID: 12358911) [PubMed]

126. Greiner J, Ringhoffer M, Simikopinko O, Szmaragowska A, Huebsch S, Maurer U, Bergmann L, Schmitt M. Simultaneous expression of different immunogenic antigens in acute myeloid leukemia. Exp Hematol 2000; 28: 1413-22. (PMID: 11146163) [PubMed]

127. Greiner J, Ringhoffer M, Taniguchi M, Schmitt A, Kirchner D, Krahn G, Heilmann V, Gschwend J, Bergmann L, Dohner H, Schmitt M. Receptor for hyaluronan acid-mediated motility (RHAMM) is a new immunogenic leukemia-associated antigen in acute and chronic myeloid leukemia. Exp Hematol 2002; 30: 1029-35. (PMID: 12225794) [PubMed]

128. Greiner J, Ringhoffer M, Taniguchi M, Hauser T, Schmitt A, Dohner H, Schmitt M. Characterization of several leukemia-associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia. Int J Cancer 2003; 106: 224-31. (PMID: 12800198) [PubMed]

129. Krackhardt AM, Witzens M, Harig S, Hodi FS, Zauls AJ, Chessia M, Barrett P, Gribben JG. Identification of tumor-associated antigens in chronic lymphocytic leukemia by SEREX. Blood 2002; 100: 2123-31. (PMID: 12200376) [PubMed]

130. Itoh M, Watanabe M, Yamada Y, Furukawa K, Taniguchi M, Hata T, Schmitt M, Ikeda H, Yamaguchi M, Ohno T, Nakashima K, Shiku H. HUB1 is an autoantigen frequently eliciting humoral immune response in patients with adult T cell leukemia. Int J Oncol 1999; 14: 703-8. (PMID: 10087317) [PubMed]

131. Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 2002; 188: 22-32. (PMID: 12445278) [PubMed]

132. Scanlan MJ, Simpson AJ, Old LJ. The cancer/testis genes: review, standardization, and commentary. Cancer Immun 2004; 4: 1. URL: http://www.cancerimmunity.org/v4p1/031220.htm (PMID: 14738373) [Abstract]

133. Ono T, Kurashige T, Harada N, Noguchi Y, Saika T, Niikawa N, Aoe M, Nakamura S, Higashi T, Hiraki A, Wada H, Kumon H, Old LJ, Nakayama E. Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc Natl Acad Sci USA 2001; 98: 3282-7. (PMID: 11248070) [PubMed]

134. Gure AO, Wei IJ, Old LJ, Chen YT. The SSX gene family: characterization of 9 complete genes. Int J Cancer 2002; 101: 448-53. (PMID: 12216073) [PubMed]

135. Naka N, Araki N, Nakanishi H, Itoh K, Mano M, Ishiguro S, de Bruijn DR, Myoui A, Ueda T, Yoshikawa H. Expression of SSX genes in human osteosarcomas. Int J Cancer 2002; 98: 640-2. (PMID: 11920629) [PubMed]

136. Alpen B, Gure AO, Scanlan MJ, Old LJ, Chen YT. A new member of the NY-ESO-1 gene family is ubiquitously expressed in somatic tissues and evolutionarily conserved. Gene 2002; 297: 141-9. (PMID: 12384295) [PubMed]

137. Li B, Qian XP, Pang XW, Zou WZ, Wang YP, Wu HY, Chen WF. HCA587 antigen expression in normal tissues and cancers: correlation with tumor differentiation in hepatocellular carcinoma. Lab Invest 2003; 83: 1185-92. (PMID: 12920247) [PubMed]

138. Usener D, Schadendorf D, Koch J, Dubel S, Eichmuller S. cTAGE: a cutaneous T cell lymphoma associated antigen family with tumor-specific splicing. J Invest Dermatol 2003; 121: 198-206. (PMID: 12839582) [PubMed]

139. Liu XF, Helman LJ, Yeung C, Bera TK, Lee B, Pastan I. XAGE-1, a new gene that is frequently expressed in Ewing's sarcoma. Cancer Res 2000; 60: 4752-5. (PMID: 10987281) [PubMed]

140. Zendman AJ, Van Kraats AA, Weidle UH, Ruiter DJ, Van Muijen GN. The XAGE family of cancer/testis-associated genes: alignment and expression profile in normal tissues, melanoma lesions and Ewing's sarcoma. Int J Cancer 2002; 99: 361-9. (PMID: 11992404) [PubMed]

141. Scanlan MJ, Welt S, Gordon CM, Chen YT, Gure AO, Stockert E, Jungbluth AA, Ritter G, Jager D, Jager E, Knuth A, Old LJ. Cancer-related serological recognition of human colon cancer: identification of potential diagnostic and immunotherapeutic targets. Cancer Res 2002; 62: 4041-7. (PMID: 12124339) [PubMed]

142. Lagarkova MA, Koroleva EP, Kuprash DV, Boitchenko VE, Kashkarova UA, Nedospasov SA, Shebzukhov YV. Evaluation of humoral response to tumor antigens using recombinant expression-based serological mini-arrays (SMARTA). Immunol Lett 2003; 85: 71-4. (PMID: 12505200) [PubMed]

143. Jager D, Stockert E, Karbach J, Herrlinger K, Atmaca A, Arand M, Chen YT, Gnjatic S, Old LJ, Knuth A, Jager E. Urine antibody against human cancer antigen NY-ESO-1. Cancer Immun 2002; 2: 10. URL: http://www.cancerimmunity.org/v2p10/020710.htm (PMID: 12747755) [Abstract]

144. Lee SY. Personal communication, 2004.

145. Ayyoub M, Rimoldi D, Guillaume P, Romero P, Cerottini JC, Valmori D, Speiser D. Tumor-reactive, SSX-2-specific CD8+ T cells are selectively expanded during immune responses to antigen-expressing tumors in melanoma patients. Cancer Res 2003; 63: 5601-6. (PMID: 14500401) [PubMed]

146. Ayyoub M, Stevanovic S, Sahin U, Guillaume P, Servis C, Rimoldi D, Valmori D, Romero P, Cerottini JC, Rammensee HG, Pfreundschuh M, Speiser D, Levy F. Proteasome-assisted identification of a SSX-2-derived epitope recognized by tumor-reactive CTL infiltrating metastatic melanoma. J Immunol 2002; 168: 1717-22. (PMID: 11823502) [PubMed]

147. Cho B, Lim Y, Lee DY, Park SY, Lee H, Kim WH, Yang H, Bang YJ, Jeoung DI. Identification and characterization of a novel cancer/testis antigen gene CAGE. Biochem Biophys Res Commun 2002; 292: 715-26. (PMID: 11922625) [PubMed]

148. Martelange V, De Smet C, De Plaen E, Lurquin C, Boon T. Identification on a human sarcoma of two new genes with tumor-specific expression. Cancer Res 2000; 60: 3848-55. (PMID: 10919659) [PubMed]

149. Mischo A, Wadle A, Watzig K, Jager D, Stockert E, Santiago D, Ritter G, Regitz E, Jager E, Knuth A, Old L, Pfreundschuh M, Renner C. Recombinant antigen expression on yeast surface (RAYS) for the detection of serological immune responses in cancer patients. Cancer Immun 2003; 3: 5. URL: http://www.cancerimmunity.org/v3p5/030605.htm (PMID: 12828452) [Abstract]

150. Cancer Immunome Database (CID). URL: http://www2.licr.org/CancerImmunomeDB/ [Database]

151. Stauffer Y, Theiler G, Sperisen P, Lebedev Y, Jongeneel CV. Digital expression profiles of human endogenous retroviral families in normal and cancerous tissues. Cancer Immun 2004; 4: 2. URL: http://www.cancerimmunity.org/v4p2/040102.htm (PMID: 14871062) [Abstract]

152. Finberg R. Personal communication, 1999.

153. Gure AO. Unpublished data, 2000.

154. Ayyoub M, Valmori D. Personal communication, 2004.

155. Jäger D. Personal communication, 2004.